The search for new revenue is becoming more urgent as physician practices absorb higher costs and less predictable growth.
In a June 2026 MGMA Stat poll, 47% of medical groups reported higher year-to-date revenue than the year before, down from 56% in the comparable 2025 poll. Thirty-six percent reported declining revenue. At the same time, 84% of medical groups reported higher year-to-date operating costs, with labor, supplies and drugs, insurance, and overhead among the pressures driving expenses higher.
The practices that are reporting stronger revenue growth cited familiar responses: greater patient volume, added providers or capacity, payer-contract improvements, expanded services and ancillaries, and stronger revenue-cycle performance.
An often overlooked opportunity may already sit inside the practice’s ancillary services. Laboratory testing that already runs through a practice can be evaluated to determine whether a different operating model could improve practice profitability.
ON THIS PAGE
Existing clinical activity can be part of the profitability equation
The opportunity is real, but the work behind it is specialized
A fully-managed path to increasing physician practice profitability through existing lab activity
The financial opportunity depends on the financial infrastructure
A laboratory strategy is one part of stronger practice performance
Existing clinical activity can be part of the profitability equation
Testing is already woven into routine clinical and operational activity. Over time, those arrangements can become part of the background of the business rather than something leadership regularly evaluates.
The reference-lab model makes this arrangement feel ordinary: the practice does the clinical work around the test, while the reimbursement follows the specimen out the door. For some practices, it does not have to.
For some practices with eligible testing and payer arrangements, outsourced testing may support client billing, allowing the physician practice to serve as the billing entity while a reference laboratory continues to perform the test.
Other practices may have the specialty panel mix, testing volume, payer environment, space, and readiness to evaluate physician-owned laboratory testing by building their own laboratory.
These opportunities change more than where a claim is submitted or where a specimen is tested. They change who owns the infrastructure around the clinical activity and what the practice would need to support it over time.
The opportunity is real, but the work behind it is specialized
A client-bill or in-house testing opportunity can look attractive on paper, but what ultimately matters to profitability is what the practice has to build, absorb, and manage in order to run those ancillary services efficiently, compliantly, and fully.
Without the right expertise and support, the complexity behind both specialized operations can quickly work against the financial opportunity.
Practices that pursue client billing without lab-specific infrastructure in place weaken the opportunity through:
- Rejected or denied claims caused by billing errors
- Delayed collections when payer requirements and claim exceptions require specialized follow-up
- Increased investments from hiring, training, or expanding internal teams to manage lab billing
- Greater management burden from coordinating multiple teams and providers into new workflows
- Delayed collections when claim and operational issues have to move through multiple handoffs before resolution
Practices that assemble a physician-owned laboratory independently can end up with several parties responsible for separate pieces of the same operation, and none of them are fully responsible for turning a successful launch into a successful lab.
The responsibility to manage the pieces and bring them together to make the lab successful after launch ultimately remains with practice leadership.
The gaps between managing those pieces can result in:
- Forecast misses caused by pro formas with assumptions that do not match reality once the lab is running
- Capital misallocation when equipment becomes underused or is not adaptable to testing changes or expansion
- Revenue cycle underperformance as generic billing vendors or teams approach lab billing like other medical billing
- Management overhead increased when leadership has to coordinate vendors and resolve ownership gaps
- Opportunity cost rises when capital and management attention stay tied up in an underperforming lab
This is where the operating model behind client billing and in-house laboratories matters as much as the opportunity itself.
A fully-managed path to increasing physician practice profitability through existing lab activity
Phytest evaluates the laboratory activity and circumstances already present in the practice and builds the lab-specific infrastructure around the opportunity that is viable. Depending on the organization, that may involve billing for eligible outsourced testing, building and managing physician-owned molecular or genetic laboratory, or a connected model integrating more than one service path.
Instead of assembling laboratory development, reimbursement and payer knowledge, staffing, compliance, reporting, and ongoing management as separate projects, the practice works within a partnership in which Phytest owns the operations behind the services and remains accountable for the functions and performance. Laboratory reimbursement expertise is the foundation of the services available, and the model is built around the environment of the practice and needs of physician leadership.
The practice remains an active participant in its clinical activity, and physicians and staff continue routine clinical behavior. Phytest owns the specialized work behind the clinical activity so the practice is not also responsible for assembling and managing the ancillary services itself.
For a practice pursuing laboratory activity partly to improve profitability, that structure is consequential. Identifying reimbursement establishes that an opportunity may exist. The way the opportunity is built and managed determines whether it has a credible path to contributing durable clinical, operational, and financial value.
+$5 million
Revenue returned to practices’ bottom line in 2025 with Phytest’s managed services
A laboratory strategy is one part of stronger practice performance
Laboratory activity occupies only one part of a physician practice’s broader economic reality. Margin pressure does, however, make the performance of each existing part of the business more important.
For an eligible practice, laboratory activity may be one area where clinical work already taking place can operate under a stronger structure and contribute more effectively to the health of the organization. That contribution depends on more than the presence of potential reimbursement. It depends on whether the right infrastructure around the opportunity is designed to support it over time.
Phytest helps physician practices evaluate that opportunity and manages the laboratory-specific services around the model that fits.
As practice leaders look for ways to protect profitability in a more difficult operating environment, existing lab activity is one piece of that larger picture, but for the right practice, it is a piece that may be capable of contributing more than the current model allows.




